[Top] [All Lists]

[e-lek] Fwd: [e-drug] Winter meeting [policy analysis] 8+9 Jan 2020: still possible to register

---------- Forwarded message ---------
From: Ham, H.A. van den (Rianne) <H.A.vandenHam@uu.nl>
Date: Wed, 18 Dec 2019 at 00:19
Subject: [e-drug] Winter meeting [policy analysis] 8+9 Jan 2020: still
possible to register
To: e-drug@healthnet.org <e-drug@healthnet.org>

E-DRUG: Winter meeting [policy analysis] 8+9 Jan 2020: still possible to

Dear E-Druggers,

The WHO Collaborating Centre for Pharmaceutical Policy and Regulation in
collaboration with the Department of Essential Medicines and Health
Products, WHO will organise a Winter Meeting on 8 + 9 January 2020 for
researchers in the field of pharmaceutical policy analysis and regulatory
science. As in previous years, we have chosen for an inspiring combination
of a central theme and key note lectures on the first day of the meeting,
and giving opportunity to (young) researchers to discuss their work with
peers on the second day.

It is still possible to register for this meeting!

Contents of the meeting
The first day of the meeting will focus on burden of disease in relation to
pharmaceutical policy, health decision-making and planning, risk factors as
central theme. In the last decade the world has experienced many shifts in
their burden of disease, e.g. more chronic conditions, outbreaks, etc..
This shift in burden of disease has important implications for the
organization of health systems and medicines supply and use. Policy makers
are expected to align their pharmaceutical policies to the prevailing
population health needs to ensure the sustainable access to medicines. All
this makes burden of disease a powerful, cross-cutting learning device for
pharmaceutical policy and regulation.

On the second day of the meeting, submitted abstracts will be presented and
discussed in the morning and afternoon (oral and poster presentations).
Abstracts are not limited to the central theme of the second day; all
research in the field of pharmaceutical policy analysis or regulatory
science is eligible for submission. The focus of the sessions will be on
methods used or proposed. (Abstract submission is closed)

Practical information
More information including practical details and registration can be found
on our website through the following link:

The full programme is also available!
Please send enquiries and abstracts to Mrs. Maud Vromen
e-mail;   uu.who.wintermeeting@gmail.com

Please feel free to share this information with others who might be
interested to join.   We look forward to welcoming you in Utrecht in

Kind regards,
on behalf of Prof. Aukje Mantel-Teeuwisse and Prof. Bert Leufkens,
Rianne van den Ham

Rianne van den Ham, PhD│Assistant professor│
WHO Collaborating Centre Pharmaceutical Policy and Regulation│Division of
Pharmacoepidemiology & Clinical Pharmacology│
Utrecht Institute for Pharmaceutical Sciences│
David de Wiedgebouw│Universiteitsweg
E-Drug, an e-forum on essential drugs, is moderated by a team of
international experts and hosted by FHI 360

To subscribe:  e-drug-join@healthnet.org
To unsubscribe:  e-drug-leave@healthnet.org
To discuss (subscribers only):  e-drug@healthnet.org
For help:  e-drug-owner@healthnet.org
For archives:  http://lists.healthnet.org/archive/html/e-drug/
<Prev in Thread] Current Thread [Next in Thread>
  • [e-lek] Fwd: [e-drug] Winter meeting [policy analysis] 8+9 Jan 2020: still possible to register, Liliya Eugenevna Ziganshina <=